An American Endometriosis Test Is Available in England. Not Here.
Two non-surgical tests for diagnosing endometriosis are now recommended by the National Health Service in the UK. One of them, called EndoSure, was developed by a Maryland-based company. Neither is available in the United States. Both are designed to detect endometriosis without laparoscopic surgery, which has been the only definitive diagnostic method for decades.
Endometriosis affects roughly one in ten women of reproductive age. The average time from first symptoms to diagnosis is ten years. That delay has been attributed to dismissed symptoms, limited diagnostic tools, and a shortage of specialists. Non-surgical testing could shorten that window significantly — but only where the tests exist.
No spam. Unsubscribe anytime.
EndoSure reads electrical signals in the gut through sensor pads placed on the abdomen. Endotest analyzes saliva for microRNAs. The NHS is recommending both for a three-year evaluation period.
EndoSure reads electrical signals in the gut through sensor pads placed on the abdomen. Endotest, a French test, analyzes saliva for microRNAs. The NHS is recommending both for a three-year evidence accumulation period. Neither is FDA-approved. EndoSure’s founder says his company is still in the process of submitting its application — FDA diagnostic approval (510k or De Novo pathway) typically takes years.
NICE guidelines cited biomarker-based testing as a tool for reducing the chronic diagnostic gap. For U.S. patients, current options remain laparoscopic surgery or clinical assessment. For specialist referrals and support: endofound.org.
Source: NHS / NICE draft guidance on endometriosis diagnostics, 2025. Maternie reporting.